T0	Disease 89 94	tumor
#1	AnnotatorNotes T0	DOID:162
T10	Chemical 520 528	estrogen
T11	Disease 520 566	estrogen receptor alpha-positive breast cancer
#3	AnnotatorNotes T11	DOID:0060075
T14	Chemical 680 688	estrogen
T15	Disease 680 750	estrogen receptor alpha-positive and lymph node-positive breast cancer
#6	AnnotatorNotes T15	DOID:0060075,not found
T18	Disease 850 867	pancreatic cancer
#8	AnnotatorNotes T18	DOID:1793
T2	Disease 158 179	neuroendocrine tumors
#10	AnnotatorNotes T2	DOID:169
T20	Disease 1112 1129	esophageal cancer
#11	AnnotatorNotes T20	DOID:5041
T22	Drug 1253 1263	paclitaxel
T23	Disease 1253 1297	paclitaxel-resistant W1 human ovarian cancer
#13	AnnotatorNotes T23	not found
T24	Disease 1404 1418	ovarian cancer
#14	AnnotatorNotes T24	DOID:2394
T27	Disease 1619 1636	pancreatic cancer
T28	Drug 1656 1659	GEM
T29	Chemical 1690 1699	glutamine
T3	Disease 191 207	pheochromocytoma
#18	AnnotatorNotes T3	DOID:0050771
T4	Disease 212 239	medullary thyroid carcinoma
#19	AnnotatorNotes T4	DOID:3973
T5	Chemical 302 324	dihydroxyphenylalanine
T7	Disease 418 435	uterine leiomyoma
#21	AnnotatorNotes T7	DOID:13223
T8	Disease 453 466	breast cancer
#22	AnnotatorNotes T8	DOID:1612
T1	Gene-Protein 602 608	SLC7A8
T6	Gene-Protein 1586 1590	LAT2
T9	Gene-Protein 1710 1714	LAT2
T13	Gene-Protein 30 34	LAT2
#2	AnnotatorNotes T13	HGNC:12749
T17	Gene-Protein 132 136	LAT2
T21	Gene-Protein 362 366	LAT2
T25	Biomarker 30 34	LAT2
#5	AnnotatorNotes T25	C419196
T26	Gene-Protein 794 798	LAT2
R1	Association Arg1:T25 Arg2:T0	
T30	Biomarker 132 154	LAT2 was overexpressed
T31	Collection 158 240	neuroendocrine tumors, including pheochromocytoma and medullary thyroid carcinoma,
T32	Gene-Protein 468 474	SLC7A8
#9	AnnotatorNotes T32	HGNC:11066
R2	Association Arg1:T30 Arg2:T31	
T33	Gene-Protein 1459 1463	LAT2
T34	Biomarker 362 366	LAT2
T35	Gene-Protein 972 978	SLC7A8
R3	Association Arg1:T34 Arg2:T7	
T36	Biomarker 468 503	SLC7A8 mRNA expression was elevated
R4	Association Arg1:T36 Arg2:T11	
T12	Biomarker 588 613	high level of SLC7A8 mRNA
R5	Prognostic-Good Arg1:T12 Arg2:T15	
T16	Biomarker 789 804	high LAT2 level
R6	Prognostic-Poor Arg1:T16 Arg2:T18	
T37	Drug-Class 1087 1108	platinum chemotherapy
T19	Gene-Protein 1206 1212	SLC7A8
T38	Biomarker 1188 1245	expression of the SLC7A8 gene was significantly decreased
#4	AnnotatorNotes T22	CHEMBL428647
T39	Gene-Protein 1347 1353	SLC7A8
R7	Association Arg1:T38 Arg2:T23	
T41	Biomarker 1586 1590	LAT2
T43	Drug 1507 1510	GEM
#7	AnnotatorNotes T43	CHEMBL888
T44	Gene-Protein 1715 1719	mTOR
#12	AnnotatorNotes T44	HGNC:3942
T45	Gene-Protein 1720 1724	LDHB
#15	AnnotatorNotes T45	HGNC:6541
T47	Gene-Protein 680 703	estrogen receptor alpha
T48	Gene-Protein 520 543	estrogen receptor alpha
#17	AnnotatorNotes T48	HGNC:3467
R9	Mediated-Non-Response Arg1:T28 Arg2:T27	
R10	Mediator Arg1:T28 Arg2:T41	
T42	Variant 925 956	single nucleotide polymorphisms
R8	Variant-Of Arg1:T35 Arg2:T42	
T40	CellLine 1500 1506	AsPC-1
T46	Biomarker 1347 1353	SLC7A8
R11	Association Arg1:T46 Arg2:T24	
R12	Mediated-Response Arg1:T37 Arg2:T20	
R13	Mediator Arg1:T37 Arg2:T42	
#16	AnnotatorNotes T46	C420646
